Femasys (FEMY) announces a partnership with Carolinas Fertility Institute. Carolinas Fertility Institute will provide the Company’s FemaSeed intratubal insemination product as an infertility treatment option to patients throughout its network in North Carolina.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Announces Public Offering and Private Placement
- Femasys prices 3.6M shares at 85c in underwritten public offering
- Femasys announces common stock offering, no amount given
- Femasys Receives Nasdaq Delisting Notice for Low Market Value
- Femasys price target lowered to $6 from $10 at JonesResearch